Description

7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine, n-Methyl-n-[(3R,4R)-4-Methyl-1-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-3-Piperidinyl]- is a high-purity, advanced pharmaceutical intermediate featuring a complex, functionalized heterocyclic structure. This compound is of significant value for medicinal chemistry research and development, particularly in the synthesis of targeted kinase inhibitors. It is primarily sought after by pharmaceutical R&D teams and fine chemical manufacturers engaged in developing novel therapeutics for oncology and other disease areas.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel small-molecule drug candidates, especially kinase inhibitors.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization programs.
• Preclinical Development: Serves as a critical starting material for producing active pharmaceutical ingredients (APIs) in development pipelines.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Biochemical Tool Compound: Potential use in biochemical assays to study specific enzyme pathways and biological mechanisms.

Basic Information

Item	Details
Product Name	7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine, n-Methyl-n-[(3R,4R)-4-Methyl-1-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-3-Piperidinyl]-
CAS No.	2504210-38-0
Molecular Formula	C17H22N8
Molecular Weight	338.41 g/mol
Synonyms	N-Methyl-N-[(3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine; (3R,4R)-N-Methyl-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine; CAS 2504210-38-0; Advanced Kinase Inhibitor Intermediate; Functionalized Pyrrolopyrimidine Derivative.
EINECS	Contact for details

Quality Control

This product is manufactured under strict quality control protocols to ensure batch-to-batch consistency and high chemical purity, suitable for demanding research applications. All batches are accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. Our quality systems are designed to support cGMP compliance for materials intended for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC/IR)	Conforms to reference standard
Assay (HPLC)	≥ 97.0%
Purity (HPLC, Area %)	≥ 98.0%
Single Unknown Impurity	≤ 0.5%
Total Impurities	≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.